AUBADE

AUBADE project provides an innovative tool that will lead professionals to a deep study, analysis, understanding, and comprehension of neurological diseases and human emotions.

AUBADE project has developed an intelligent, multisensor and wearable system for the assessment of the emotional state of humans under special conditions. The project has involved the utilization of innovative technologies such as the recognition of the emotions after the processing of the following biomedical signals: EMG, obtained from the face of the users, ECG, skin conductivity and respiration rate.

AUBADE results in a modular and multifunctional system to be applicable in different areas. Initially it is being be utilized in the health sector, primarily in the neurology and psychology areas, and also in the car racing sector.

AUBADE objective is the implementation of an intelligent, multisensorial wearable system that can ubiquitously monitor and classify the emotional state of users in near time using signals mainly obtained from their faces.

AUBADE platform incorporates a wearable system that obtains signals from multiple appropriate biosensors mainly placed on the face of the user (EMG, ECG, skin conductivity and respiration rate). The system is being used in a variety of healthcare applications mainly in the neurology and psychology field. Additionally, there are other areas of application, as the racing car sector.

AUBADE has been designed to be highly modular and can be easily adapted or break-up in stand alone modules, in order to accommodate a wide variety of neurological and psychological conditions.

For further information, please visit:
http://www.aubade-group.com

Project co-ordinator:
SIEMENS, S.A.

Partners:

  • SIEMENS, S.A. (ES)
  • AZIENDA UNITA SANITARIA LOCALE DI MODENA (IT)
  • ANCO S.A. Agencies, Commerce & Industry (GR)
  • University of Ioannina (GR)
  • MASERATI S.P.A. (IT)

Timetable: from 01/04 - to 07/06

Total cost: € 3.567.434,98

EC funding: € 2.000.000

Instrument: STREP

Project Identifier: IST-2002-507605

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...